Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Procainamide
Drug ID BADD_D01842
Description A derivative of procaine with less CNS action.
Indications and Usage For the treatment of life-threatening ventricular arrhythmias.
Marketing Status Prescription; Discontinued
ATC Code C01BA02
DrugBank ID DB01035
KEGG ID D08421
MeSH ID D011342
PubChem ID 4913
TTD Drug ID D0U5SI
NDC Product Code Not Available
Synonyms Procainamide | Procaine Amide | Amide, Procaine | Biocoryl | Novocainamide | Novocamid | Procainamide Hydrochloride | Hydrochloride, Procainamide | Procan | Procan SR | Procanbid | Pronestyl | Rhythmin | Apo-Procainamide | Procamide
Chemical Information
Molecular Formula C13H21N3O
CAS Registry Number 51-06-9
SMILES CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
HepatotoxicityCytochrome P450 2D6P10635T573929352574; 6166442
HepatotoxicityCytochrome P450 2D6P10635T57392Not Available
Poisoning and toxicityCytochrome P450 2D6P10635T573929352574; 6166442
Poisoning and toxicityCytochrome P450 2D6P10635T57392Not Available
Sudden cardiac deathPotassium voltage-gated channel subfamily KQT member 1P51787T495269927398; 10810773; 10082151; 10408028
Sudden cardiac deathSodium channel protein type 5 subunit alphaQ14524T397169927398; 10810773; 10082151; 10408028
Sudden cardiac deathPotassium voltage-gated channel subfamily E member 1P15382Not Available9927398; 10810773; 10082151; 10408028
Sudden cardiac deathPotassium voltage-gated channel subfamily H member 2Q12809T202519927398; 10810773; 10082151; 10408028
Systemic lupus erythematosusN-alpha-acetyltransferase 20P61599Not AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hallucination19.10.02.002--
Hepatic failure09.01.03.002--
Hepatomegaly09.01.05.001--Not Available
Hypergammaglobulinaemia01.05.01.010; 10.02.01.016--Not Available
Hypersensitivity10.01.03.003--
Hypotension24.06.03.002--
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
Malaise08.01.01.003--
Myalgia15.05.02.001--
Nausea07.01.07.001--
Neutropenia01.02.03.004--Not Available
Oliguria20.01.03.004--Not Available
Pericarditis02.06.02.001--
pH urine decreased13.13.02.023--Not Available
Pleural effusion22.05.02.002--
Pruritus23.03.12.001--
Pyrexia08.05.02.003--
Rash maculo-papular23.03.13.004--
Renal failure20.01.03.005--Not Available
Seizure17.12.03.001--
Shock24.06.02.002--Not Available
Supraventricular tachycardia02.03.03.012--
Systemic lupus erythematosus23.03.02.006; 15.06.02.003; 10.04.03.004--Not Available
Thrombocytopenia01.08.01.002--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vasculitis24.05.02.001; 10.02.02.006--
Ventricular fibrillation02.03.04.008--
Ventricular tachycardia02.03.04.010--
Vomiting07.01.07.003--
Lupus-like syndrome10.04.03.003; 23.03.02.004; 15.06.02.004--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages